Is Intraprise Health HIPAA One™ a good alternative to C2 Controls Maturity Assessment?

Intraprise Health HIPAA One™ and C2 Controls Maturity Assessment serve similar Compliance Management use cases: both are Compliance Management tools, both cover Security Audit. Review the feature comparison above to determine which fits your requirements.

Intraprise Health HIPAA One™ vs C2 Controls Maturity Assessment (2026)

Q: What is the difference between Intraprise Health HIPAA One™ vs C2 Controls Maturity Assessment?

**Intraprise Health HIPAA One™**: Cloud-based HIPAA compliance software for healthcare organizations. built by Intraprise Health. headquartered in United States. Core capabilities include Automated Security Risk Assessments (SRA), Privacy/Breach Risk Assessments (PBRA), Automated risk calculation and prioritization.. **C2 Controls Maturity Assessment**: Controls maturity assessment platform for compliance & risk management. built by C2 Risk. headquartered in United Kingdom. Core capabilities include Control framework identification and visualization, Risk-based control assessment and evaluation, Customizable compliance assessments with evidence requests.. Both serve the Compliance Management market but differ in approach, feature depth, and target audience.

Q: What features do Intraprise Health HIPAA One™ vs C2 Controls Maturity Assessment offer?

**Intraprise Health HIPAA One™** differentiates with Automated Security Risk Assessments (SRA), Privacy/Breach Risk Assessments (PBRA), Automated risk calculation and prioritization. **C2 Controls Maturity Assessment** differentiates with Control framework identification and visualization, Risk-based control assessment and evaluation, Customizable compliance assessments with evidence requests.

Q: Who makes Intraprise Health HIPAA One™ vs C2 Controls Maturity Assessment?

**Intraprise Health HIPAA One™** is developed by Intraprise Health. **C2 Controls Maturity Assessment** is developed by C2 Risk. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.